Vericel officer sells 2,732 shares at $44.90
Vericel Corp’s Principal Accounting Officer Jonathan Siegal reported a same-day option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vericel Corp’s Principal Accounting Officer Jonathan Siegal reported a same-day option exercise and share sale. On June 26, 2026, he exercised 2,500 stock options at $29.82 per share and sold a total of 2,732 common shares at $44.90 per share in open-market transactions.
Following these trades, he holds 886 common shares directly and 6,500 stock options that remain outstanding and exercisable through February 17, 2033. The filing notes the sales were made under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
SIEGAL JONATHAN
Role
Principal Accounting Officer
Sold
2,732 shs ($123K)
Approx. gross sale proceeds
$123K
Approx. exercise cost
$75K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | $0.00 |
| Sale | Common Stock | 232 | $44.90 | $10K |
| Exercise | Common Stock | 2,500 | $29.82 | $75K |
| Sale | Common Stock | 2,500 | $44.90 | $112K |
Holdings After Transaction:
Stock Option (Right to Buy) — 6,500 contracts (Direct);
Common Stock — 886 shares (Direct)
Footnotes (3)
- F1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
- F2. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F3. These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Key Figures
Shares sold: 2,732 shares
Sale price: $44.90 per share
Options exercised: 2,500 shares
+5 more
8 metrics
Shares sold
2,732 shares
Common stock sold on June 26, 2026
Sale price
$44.90 per share
Open-market sale price for common stock
Options exercised
2,500 shares
Stock options exercised into common stock
Option exercise price
$29.82 per share
Strike price of exercised stock options
Shares held after
886 shares
Direct common stock holdings after transactions
Options remaining
6,500 options
Stock options outstanding after exercise
Option expiration
February 17, 2033
Expiration date of remaining stock options
Net share change
-2,732 shares
Net sell direction in transaction summary
Key Terms
Rule 10b5-1 trading plan, Employee Stock Purchase Plan, Stock Option (Right to Buy), Rule 16b-3(d), +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Purchase Plan financial
"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions..."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... representing the right to purchase 9,000 shares..."
Rule 16b-3(d) regulatory
"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Vericel (VCEL) report for Jonathan Siegal?
Vericel reported that Principal Accounting Officer Jonathan Siegal exercised 2,500 stock options and sold 2,732 common shares. The sales occurred in open-market trades at $44.90 per share, as part of a routine Form 4 insider transaction disclosure.
At what prices did the Vericel (VCEL) insider trades occur?
The Form 4 shows Siegal exercised stock options at $29.82 per share and sold common shares at $44.90 per share. These prices reflect the option strike level and the actual open-market sale price on the transaction date.
Were the Vericel (VCEL) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote explains that the sales were executed automatically under a Rule 10b5-1 trading plan adopted on December 10, 2025. Such plans pre-schedule trades, reducing the significance of short-term market timing for these insider sales.
What do the exercised Vericel (VCEL) stock options in the Form 4 represent?
The exercised options represent the right to buy 2,500 Vericel shares at $29.82 per share. A footnote notes these options were part of a 9,000-share grant that vests quarterly, contingent on continued service to the company.
When do Jonathan Siegal’s remaining Vericel (VCEL) stock options expire?
The remaining 6,500 Vericel stock options shown in the filing expire on February 17, 2033. This long-dated expiration allows an extended period during which Siegal can choose to exercise those options, subject to their vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates